Anastasiia Makushina

Dr. Anastasiia Makushina


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2019 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
OSO. A. Storonova
O. A. Storonova
ATA. S. Trukhmanov
A. S. Trukhmanov
AMAnastasiia Makushina
Anastasiia Makushina
APA. V. Paraskevova
A. V. Paraskevova
VIV. T. Ivashkin
V. T. Ivashkin
Aim. The present articleidentifies possible correlations between new parameters for impedance–pH monitoring, such as mean nocturnal baseline impedance (MNBI); post-reflux swallow-induced peristaltic wave index (PSPW); and the main parameter, acid exposure time (AET), as well as esophageal motor function. The authors set out to assess the values of MNBI and the PSPW index as additional criteria improving the diagnostic efficacy of impedance-pH monitoring, the completeness of clinical phenotyping of gastroesophageal reflux disease (GERD), as well as determining the probability of a more severe disease course. Materials and methods. A total of 60 patients aged 19 to 71 (mean age 44.7 years) participated in the study: 30 patients with erosive reflux disease (ERD), 30 with non-erosive reflux disease (NERD) and 20 healthy volunteers aged 26 to 65 (mean age 45.2 years). All of them underwent 24-hour combined esophageal impedance–pH monitoring (Gastroscan-IAM, JSC RPE Istok-Sistema, Fryazino) and high-resolution esophageal manometry using a 22-channel water-perfusion catheter (Solar GI MMS, The Netherlands). The authors studied such parameters as AET, GER number, MNBI level, PSPW index, distal contractile integral (DCI), resting pressure in the lower esophageal sphincter (LES), peristaltic break. Statistical processing was performed using Statistica for Windows 10.0 (StatSoft Inc.) and Prism 8 (GraphPad).Results. The examination of patients revealed that MNBI, the PSPW index and DCI significantly decrease with the development of more severe GERD (r = -0.79; p = 0.0000, r = -0.4; p = 0.0002, r = -0.49; p = 0.0000, respectively). A negative correlation was found between AET and the PSPW index (r = -0.38; p = 0.0003) and the MNBI level (r = -0.59; p = 0.0000). A correlation was determined between the value of MNBI and the following parameters: LES resting pressure (r = 0.26; p = 0.0006), DCI (r = 0.35; p = 0.00004), peristaltic break (r = -0.21; p = 0.007), the PSPW index (r = 0.41; p = 0.0000), and GER number (r = -0.59; p = 0.0). A correlation between the PSPW index and DCI (r = 0.22; p = 0.001) was found as well.In the group of ERD patients, the median values of PSPW and MNBI constitute 0.23 [0.17; 0.33] and 1.13 [0.63; 1.53], respectively. Also, a correlation between AET and the MNBI level was found in this group of patients (r=-0.53; p=0.000036). In turn, MNBI correlated with LES resting pressure (r = 0.46; p = 0.0004), DCI (r = 0.36; p = 0.005), peristaltic break (r = -0.37; p = 0.004), and GER number (r = -0,42; p = 0,0000).In the group of NERD patients, the median values of PSPW and MNBI constitute 0.56 [0.51; 0.75] and 3.3 [2.57; 4.8], respectively. A correlation was also found between the MNBI level and AET (r = -0.35; p = 0.005), GER number (r = -0.39; p = 0.00005), as well as between AET and the PSPW index (r = -0.26; p = 0.0000).In the control group, the median values of PSPW and MNBI constitute 0.42 [0.3; 0.5] and 5.83 [5.21; 6.48], respectively. A statistically significant difference (p = 0.02) was found between the median values of MNBI in patients with ERD, NERD, and the control group. A statistically significant difference (p = 0.0) between the median values of the PSPW index in patients with ERD, NERD and the control group was found as well.Conclusions. The revealed correlations between AET, esophageal motor function and new parameters for impedance-pH monitoring allow them to be used as additional criteria improving the diagnostic efficacy of impedance-pH monitoring and the completeness of GERD clinical phenotyping. A decrease in the level of these parameters in patients reflects the probability of a more severe disease course.

3 December 2020 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
VIVladimir Ivashkin
Vladimir Ivashkin
NYN. D. Yuschuk
N. D. Yuschuk
IMIgor V. Maev
Igor V. Maev
ATA. S. Trukhmanov
A. S. Trukhmanov
OSO. A. Storonova
O. A. Storonova
ЮУЮ. П. Успенский
Ю. П. Успенский
Aim. Current clinical recommendations aim to provide gastroenterologists, general practitioners (family doctors), endoscopists and infectionists with modern methods for diagnosis and treatment of infectious esophagitis.Key points. Infectious esophagitis is an esophageal disease of fungal, viral, bacterial or parasitic origin. Esophagus may be affected per se or conjointly in a common gastrointestinal infection. All patients suspected for infectious esophagitis, unless contraindicated, are advised an esophagogastroduodenoscopy with biopsy to confirm diagnosis. Selected incidents of infectious esophagitis require a histological, immunohistochemical examination or polymerase chain reaction-based diagnosis to verify the infectious agent. Uncomplicated infectious esophagitis requires a conservative therapy, mostly on an outpatient basis. However, cases of severe odynophagia, dysphagia, severe pain syndrome, high complication risks (e.g., esophageal ulcer bleeding in thrombocytopenia), severe immunodeficiency, generalised forms of disease and severe concomitant disorders are considered for hospital care. The clinical recommendations outline criteria for the medical care quality assessment and provide relevant information to the patient.Conclusion. Diagnosis of infectious esophagitis capitalises on the clinical picture (odynophagia, dysphagia), presence of immunosuppression, endoscopic and histological evidence. All patients with infectious esophagitis of verified origin are recommended a suitable etiotropic therapy.

23 May 2024 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
OSO. A. Storonova
O. A. Storonova
APA. V. Paraskevova
A. V. Paraskevova
AMAnastasiia Makushina
Anastasiia Makushina
Aim: to present data on the role of bile acids in the progression of Barrett's esophagus (BE) and the development of esophageal dysplasia and adenocarcinoma and to provide a rationale for the use of ursodeoxycholic acid in addition to basic therapy in patients with gastroesophageal reflux disease (GERD).Key points. The prevalence of GERD in the world is 13.98 %. In the absence of the necessary treatment or non-compliance with the recommended regimens and duration of drug use, complications of GERD develop such as stricture, bleeding, BE, which, in turn, is a risk factor for the development of esophageal adenocarcinoma (EAC). The basic therapy for GERD is proton pump inhibitors (PPIs), but up to 40 % of patients do not fully respond to PPI monotherapy, which indicates the need to consider, among the factors in the pathogenesis of GERD, the persistence of weakly acidic and weakly alkaline refluxes, the presence of which can be diagnosed by performing 24-hour impedance-pH monitoring. It has been proven that refluxate is predominantly acidic in nature in 50 % of patients with GERD, acidic with a bile component in 39.7 %, and 10.3 % of patients have bile reflux. The weaklly alkaline nature of reflux, due to the presence of duodenal contents, significantly increases the incidence of intestinal metaplasia with dysplasia and EAC compared to acidic pH values. Therefore, stopping duodenal reflux may be an important step in preventing the development of EAC. Among the components of duodenal contents that have a damaging effect on the mucous membrane of the esophagus, the role of bile acids has been most studied. The presence of hydrophobic bile acids, namely deoxycholic acid (DCA), is associated with oxidative DNA damage in lesions of intestinal-type columnar cell metaplasia. Ursodeoxycholic acid (UDCA), a hydrophilic bile acid, is a natural competitive inhibitor of DCA and prevents DNA damage and nuclear factor-κB (NF-κB) activation caused by toxic bile acids in BE epithelial cells. The cytoprotective effect of UDCA, aimed at preventing DNA damage and increasing the reparative capacity of cells in the metaplastic epithelium of the BE, allows us to consider this drug as a means of chemoprophylaxis in patients diagnosed with GERD.Conclusion. The addition of UDCA drugs to the basic therapy is pathogenetically justified in patients with GERD in the presence of duodenogastroesophageal reflux. Prescribing complex therapy will reduce the incidence of esophagitis, progression of BE with the development of dysplasia and adenocarcinoma caused by exposure to bile acids.

1 January 2025 in Voprosy detskoj dietologii
Verified
Journal Article
Closed access
AMAnastasiia Makushina
Anastasiia Makushina
ATA.S. Trukhmanov
A.S. Trukhmanov
OSO.A. Storonova
O.A. Storonova
APA.V. Paraskevova
A.V. Paraskevova
PEP.G. Ermishina
P.G. Ermishina
VIVladimir Ivashkin
Vladimir Ivashkin
Objective. To evaluate the effect of combination therapy with rebamipide and proton pump inhibitor (PPI) on the functional state of the esophagus in patients with non-erosive reflux disease (NERD). Patients and methods. The study included 60 patients, 39 of whom had a confirmed diagnosis of NERD and were randomized into two groups: the study group receiving combination therapy with rebamipide (300 mg/day) and omeprazole (20 mg/day), and the comparison group receiving omeprazole monotherapy (20 mg/day). The study also included 13 patients with functional heartburn and 8 patients with esophageal hypersensitivity, who were divided into two groups. The duration of treatment was four weeks. To assess the functional state of the esophagus and gastroesophageal junction, as well as the esophageal mucosal resistance, the values of esophageal 24-hour pH-impedance testing and high-resolution manometry before and after treatment were analyzed. Results. In patients with NERD receiving combination therapy, the percentage of time with pH <4 was statistically significantly lower in the follow-up examination after the end of treatment and withdrawal of medications compared to the period before treatment (p = 0.048). In patients receiving PPI monotherapy, no statistically significant changes in the percentage of time with pH <4 were found in the dynamics (p = 0.465). There were statistically significant differences in lower esophageal sphincter pressure between two groups after treatment (p = 0.017). However, analyzing this parameter within each group before and after treatment revealed no statistically significant changes in lower esophageal sphincter pressure. In patients with esophageal hypersensitivity and functional heartburn, changes in the values of esophageal 24-hour pH-impedance testing and highresolution manometry before and after treatment did not reach statistical significance in any of the examined groups. Conclusion. The use of combination therapy with PPI and rebamipide is a safe and effective method to achieve adequate acid suppression, including in the post-treatment period. This therapeutic approach may improve esophageal motility and the state of lower esophageal sphincter. Key words: proton pump inhibitors, non-erosive reflux disease, epithelial protective therapy

25 June 2025 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
AMAnastasiia Makushina
Anastasiia Makushina
ATA. S. Trukhmanov
A. S. Trukhmanov
APA. B. Ponomarev
A. B. Ponomarev
OSO. A. Storonova
O. A. Storonova
APA. V. Paraskevova
A. V. Paraskevova
VIVladimir Ivashkin
Vladimir Ivashkin
Aim: to evaluate the effect of combined therapy with a proton pump inhibitor and rebamipide on clinical manifestations and morphofunctional changes in the esophageal mucosa in patients with non-erosive reflux disease.Materials and methods. The study included 39 patients with non-erosive reflux disease randomized into the main group (omeprazole 20 mg/day + rebamipide 300 mg/day) and the comparison group (omeprazole 20 mg/day). The duration of treatment was 4 weeks. Histological examination of esophageal mucosa biopsies (hematoxylin-eosin staining), morphometry of intercellular spaces, and immunohistochemical assessment of tight junction protein expression (claudin-1, -4, occludin) were performed. Symptoms were evaluated using the Likert scale.Results. The combined therapy group showed significant reductions in heartburn severity (p < 0.001) and belching (p = 0.004), with absent/mild symptoms in 63.7 and 72.4 % of patients, respectively. In the proton pump inhibitor monotherapy group, 53 % of patients retained moderate or severe heartburn. Morphologically, the combined group demonstrated reduced eosinophilic infiltration (p = 0.030). Occludin expression increased in both groups but reached statistical significance only in the monotherapy group (p = 0.046).Conclusion. The combined therapy with proton pump inhibitor and rebamipide improves symptoms and morphological outcomes in non-erosive reflux disease. Increased occludin expression suggests restored integrity of intercellular junctions. Further studies with larger cohorts and extended follow-up are needed to confirm these findings.

30 September 2022 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
AMAnastasiia Makushina
Anastasiia Makushina
OSO. A. Storonova
O. A. Storonova
ATA. S. Trukhmanov
A. S. Trukhmanov
TLT. L. Lapina
T. L. Lapina
VIVladimir Ivashkin
Vladimir Ivashkin
Background: Eosinophilic esophagitis (EoE) is the second most common cause of esophagitis. Topical steroids represent a promising group of drugs for inducing and maintaining clinical and histological remission in these patients.Objective. To evaluate the effectiveness of topical steroids in inducing and maintaining clinical and histological remission in adolescent and adult patients with EoE.Methods. A systematic literature search using defined keywords was performed up to March 20, 2021 in the MEDLINE / PubMed, EMBASE (Excerpta Medica), and Cochrane Central Register of Controlled Trials, ClinicalTrial.gov databases.Results. 390 patients from 5 studies were included in this systematic review with meta-analysis. The meta-analysis showed that topical steroids, compared with placebo, was more effective in inducing (odds ratio (OR) 75.77; 95 % confidence interval (CI): (21.8; 263.41), p < 0.001) and maintaining complete histological remission (OR 103.65; 95 % CI: (36.05; 298.01), p < 0.001) in patients with EoE. Also, topical steroids significantly relieved disease symptoms compared with placebo in inducing and maintaining clinical remission (OR 4.86; 95 % CI: (1.4; 16.86), p = 0.01) and (OR 11.06; 95 % CI: (4.62; 26.45), p < 0.001) respectively.Conclusions. Topical steroids represent an effective group of drugs for inducing and maintaining histologic and clinical remission in adolescent and adult patients with EoE.